ReviewCureus2026
Spontaneous Spinal Epidural Haematoma Associated With Direct Oral Anticoagulants: A Descriptive Systematic Review.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Direct oral anticoagulant (DOAC)-associated spontaneous spinal epidural haematoma (SSEH) is an uncommon but potentially devastating haemorrhagic complication that can cause acute spinal cord compression. Current evidence is limited to case reports, case series, and accompanying narrative reviews, with no comprehensive systematic synthesis of the available evidence. A systematic review was conducted in accordance with PRISMA 2020 guidelines. MEDLINE via PubMed was searched from database inception to March 2026 using predefined search terms, with additional studies identified through backward citation searching. Studies reporting atraumatic SSEH in adults receiving DOACs were included. Traumatic, iatrogenic, and non-epidural haemorrhages were excluded. Data extracted included patient demographics, DOAC type, clinical presentation, diagnostic pathway, management, and neurological outcomes. A descriptive synthesis was performed. A total of 17 studies comprising 21 patients met the inclusion criteria. Rivaroxaban and apixaban were the most frequently implicated DOACs. Patients typically presented with acute neck or back pain followed by rapidly progressive neurological deficits, with several cases initially mimicking acute stroke. MRI was the most frequently utilised imaging modality, while CT also identified the haematoma in several patients, either alone or before subsequent MRI. Management was predominantly surgical decompression, although four patients were managed conservatively. Complete or partial neurological recovery was reported in 18/21 patients. DOAC-associated SSEH is a rare but time-critical neurological emergency. Early recognition, prompt imaging, and timely intervention remain fundamental to optimising neurological outcomes. As the use of DOACs continues to increase, clinician awareness of this uncommon complication is essential to facilitate early diagnosis and appropriate management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.